title: Reply to the letter to the editor: bimonthly injections of ranibizumab for age-related macular degeneration.
authors.affiliation: Department of Ophthalmology, Shiga University of Medical Science, Seta Tsukinowacho, Otsu, Shiga, 520-2192, Japan, tsawada@belle.shiga-med.ac.jp.
authors.forename: Tomoko
authors.initials: T
authors.lastname: Sawada
authors.forename: Masahito
authors.initials: M
authors.lastname: Ohji
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D020256:Choroidal Neovascularization / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008268:Macular Degeneration / Q000188:drug therapy*; D008297:Male; D011127:Polyps / Q000188:drug therapy*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized